Diligence memo · auto-generated · as of July 2, 2026
Xymogen, Inc.
Xymogen, Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Xymogen, Inc. operates in Other Health Care, based in ORLANDO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Xymogen, Inc. has raised $62M in disclosed capital across 21 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $4.0M on 2012-07-01.
Most recent recorded round closed around 2025-05-12.
Valuation (modeled)modeled
Provath models Xymogen, Inc. at approximately $12M (range $3.4M–$26M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.89× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 12 months.
Last raise 14 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 1.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 94% of Other Health Care peers (5377 compared).
Modeled value ranks above 38% of those peers.
Closest niche peers: Willow Life Sciences, Inc., ManyClicks, Inc., Sterile State, Inc., Limber Prosthetics, Inc., Othership Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.